| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
4e-13 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
8e-13 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-12 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
2e-12 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-12 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-10 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-10 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-10 |
| mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-10 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-09 |